FOXO4-DRI 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only – not for human or veterinary use.

Product Overview
FOXO4-DRI is a research peptide evaluated for its relevance to cellular-senescence models, biochemical signalling pathways and experimental modulation of age-associated cell-cycle behaviour. This lyophilized 10 mg peptide supports controlled laboratory analysis of identity, purity and mechanistic properties.

Peptide Overview
Between 2015 and 2025 scientific interest in FOXO4-DRI expanded significantly as research groups examined selective interactions with senescent-cell pathways and mechanisms linked to cell-survival signalling. Its defined molecular profile supports structured evaluation within in-vitro biochemical systems.

Historical Background and Scientific Context
Senescence-related biochemical pathways became a major research focus from 2014 onward. FOXO4-DRI gained recognition in studies investigating cell-cycle arrest, apoptosis-related signalling and interactions between transcription-factor pathways and cellular-aging markers. Its reproducibility makes it suitable for repeatable laboratory modelling.

Mechanistic Focus in Research

• Cellular-senescence modelling
• Evaluation of FOXO-pathway related signalling
• In-vitro assessment of biochemical stress-adaptation
• Comparative analysis of senescence-modulating peptides
• Structure–function profiling under controlled laboratory conditions

Analytical Verification (COA)
Independent Liquilabs analysis confirms full analytical validation for Batch GF082025009. Key results include:

• Assay Content: 10.57 mg
• Identification – Retention Time: 0.997
• Identification – Spectrum: 998
• Purity: above 99.8 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count, yeast or mold
• Heavy Metals: not detected including arsenic cadmium lead mercury nickel cobalt vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological methodologies ensuring transparent documentation and traceability.

Research Applications

• Senescence-pathway biochemical modelling
• Stress-response and cell-cycle regulation studies
• Comparative laboratory evaluation of regulatory peptides
• In-vitro analysis of transcription-factor related pathways
• Controlled biochemical modelling experiments

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• Endotoxin below 0.001 EU per mg
• No detectable heavy metals or microbial contamination
• Batch GF082025009 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.